Cantor Fitzgerald Downgrades Opiant Pharma (OPNT) to Neutral on Acqusition
Tweet Send to a Friend
Cantor Fitzgerald analyst Brandon Folkes downgraded Opiant Pharma (NASDAQ: OPNT) from Overweight to Neutral with a price target of $21.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
